Your browser doesn't support javascript.
loading
Self-assembled dual fluorescence nanoparticles for CD44-targeted delivery of anti-miR-27a in liver cancer theranostics.
Zheng, Xiao; Zhang, Fan; Zhao, Yawei; Zhang, Jing; Dawulieti, Jianati; Pan, Yue; Cui, Lianzhi; Sun, Madi; Shao, Dan; Li, Mingqiang; He, Kan; Zhang, Ming; Li, Jing; Chen, Li.
Afiliación
  • Zheng X; Department of Pharmacology, Nanomedicine Engineering Laboratory of Jilin Province, College of Basic Medical Sciences, Jilin University, Changchun 130021, China.
  • Zhang F; Department of Pharmacology, Nanomedicine Engineering Laboratory of Jilin Province, College of Basic Medical Sciences, Jilin University, Changchun 130021, China.
  • Zhao Y; Department of Pharmacology, Nanomedicine Engineering Laboratory of Jilin Province, College of Basic Medical Sciences, Jilin University, Changchun 130021, China.
  • Zhang J; Department of Pharmacology, Nanomedicine Engineering Laboratory of Jilin Province, College of Basic Medical Sciences, Jilin University, Changchun 130021, China.
  • Dawulieti J; Department of Pharmacology, Nanomedicine Engineering Laboratory of Jilin Province, College of Basic Medical Sciences, Jilin University, Changchun 130021, China.
  • Pan Y; Department of Pharmacology, Nanomedicine Engineering Laboratory of Jilin Province, College of Basic Medical Sciences, Jilin University, Changchun 130021, China.
  • Cui L; Clinical Laboratory, Jilin Cancer Hospital, Changchun 130012, China.
  • Sun M; Department of Pharmacology, Nanomedicine Engineering Laboratory of Jilin Province, College of Basic Medical Sciences, Jilin University, Changchun 130021, China.
  • Shao D; Department of Pharmacology, Nanomedicine Engineering Laboratory of Jilin Province, College of Basic Medical Sciences, Jilin University, Changchun 130021, China.
  • Li M; Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA.
  • He K; Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA.
  • Zhang M; Department of Pharmacology, Nanomedicine Engineering Laboratory of Jilin Province, College of Basic Medical Sciences, Jilin University, Changchun 130021, China.
  • Li J; Department of Pharmacology, Nanomedicine Engineering Laboratory of Jilin Province, College of Basic Medical Sciences, Jilin University, Changchun 130021, China.
  • Chen L; Department of Pharmacology, Nanomedicine Engineering Laboratory of Jilin Province, College of Basic Medical Sciences, Jilin University, Changchun 130021, China.
Theranostics ; 8(14): 3808-3823, 2018.
Article en En | MEDLINE | ID: mdl-30083261
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: MicroARNs / Nanopartículas / Terapia Molecular Dirigida / Nanomedicina Teranóstica / Antagomirs / Neoplasias Hepáticas / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Theranostics Año: 2018 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: MicroARNs / Nanopartículas / Terapia Molecular Dirigida / Nanomedicina Teranóstica / Antagomirs / Neoplasias Hepáticas / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Theranostics Año: 2018 Tipo del documento: Article País de afiliación: China